Germline genetic contributions to risk for esophageal adenocarcinoma, Barretts esophagus, and gastroesophageal reflux
This gradual dose escalation is designed to minimize common adverse effects, particularly gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation
While specific EMA timelines for next-generation oral GLP-1s have not been announced, the progress seen with the FDA is a promising indicator
Pouya Shafipour, MD, a family and obesity medicine physician at Providence Saint Johns Health Center in Santa Monica, CA, said a pill form of Ozempic will likely be more appealing to many people than an injection
oral semaglutide's impact on cardiovascular outcomes in T2DM patients, aiming to clarify whether the two formulations demonstrate consistent efficacy in reducing cardiovascular events and mortality
When it comes to risk, its not just melanotan itselfits that its unregulated